In order to increase the translational significance of our results, we also evaluated the impact of p38α pharmacological inhibition on c-Myc expression in patients-derived CRC-SCs and patient-derived tumor intestinal organoids (Fig. 8A). The gene discussed is MYC; the disease is colorectal carcinoma.